Clinical Trials Directory

Trials / Completed

CompletedNCT06404827

The Effect of Hippotherapy Simulator in Children with Spastic Cerebral Palsy

Investıgatıon of the Effect of Hıppotherapy Sımulator on Lower Extremıty Selectıve Motor Control, Balance and Trunk Control in Chıldren Wıth Spastıc Cerebral Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Hasan Kalyoncu University · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The horseback riding simulator (HRS) is a dynamic robotic device that mimics the movement of a horse for hippotherapy purposes. HRS aims to improve the patient's balance, adaptation and provide postural adjustment by mimicking the rhythmic movements of the horse. This study aims to research the potential benefits of the horseback riding simulator on the lower extremity selective motor control, balance and trunk control in children with Cerebral palsy.

Detailed description

Between the dates of the study, children with Cerebral palsy (CP) who meet the inclusion criteria will be allocated into two groups (intervention group, control group) by randomiZation method. Intervention group: horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation. This group will receive 20 minutes of routine physiotherapy training and 20 minutes of HRS application in addition to 2 sessions per week for 8 weeks. Control group: Routine physiotherapy training will be applied within a specific programme for 40 minutes in 2 sessions per week for 8 weeks. All the assessments will be performed before and after the training in the 8-week groups.

Conditions

Interventions

TypeNameDescription
OTHERHorseback riding simulatorHorseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation.
OTHERRoutine Physiotherapy and RehabilitationRoutine Physiotherapy and Rehabilitation within a spesific programme

Timeline

Start date
2024-02-20
Primary completion
2024-11-20
Completion
2024-11-21
First posted
2024-05-08
Last updated
2025-01-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06404827. Inclusion in this directory is not an endorsement.